Home/Filings/4/0000950170-24-076410
4//SEC Filing

Readnour Robin Shane 4

Accession 0000950170-24-076410

CIK 0001880438other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 6:22 PM ET

Size

17.5 KB

Accession

0000950170-24-076410

Insider Transaction Report

Form 4
Period: 2024-06-19
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-19+64,50364,503 total
    Exercise: $2.00Exp: 2034-06-18Common Stock (64,503 underlying)
Footnotes (1)
  • [F1]The option shares shall vest on the earlier of (a) the one-year anniversary of June 19, 2024 or (b) the day prior to the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person providing continuous service through such vesting date.

Issuer

AN2 Therapeutics, Inc.

CIK 0001880438

Entity typeother

Related Parties

1
  • filerCIK 0001914883

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 6:22 PM ET
Size
17.5 KB